|
Heart failure - basic studies
Citations 271-280 of 533 total displayed.
|
Past content
(since Jan 1999):
|
- Basic Science Reports
ß1-Adrenergic Receptor Blockade Attenuates Angiotensin II–Mediated Catecholamine Release Into the Cardiac Interstitium in Mitral Regurgitation
- José Tallaj, Chih-Chang Wei, Gerald H. Hankes, Merrilee Holland, Patricia Rynders, A. Ray Dillon, Jeffrey L. Ardell, J. Andrew Armour, Pamela A. Lucchesi, and Louis J. Dell’Italia
Circulation 2003;108:225-230; published online before print as doi:10.1161/01.CIR.0000079226.48637.5A
[Abstract]
[Full text]
- Articles
 1-Adrenergic Receptor Blockade Attenuates Angiotensin II-Mediated Catecholamine Release Into the Cardiac Interstitium in Mitral Regurgitation
- José Tallaj, Chih-Chang Wei, Gerald H. Hankes, Merrilee Holland, Patricia Rynders, A. Ray Dillon, Jeffrey L. Ardell, J. Andrew Armour, Pamela A. Lucchesi, and Louis J. Dell'Italia
Circulation published July 7, 2003, doi:10.1161/01.CIR.0000079226.48637.5A
[Abstract]
- Clinical Investigations and Reports
Interferon-ß Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction
- Uwe Kühl, Matthias Pauschinger, Peter Lothar Schwimmbeck, Bettina Seeberg, Conny Lober, Michel Noutsias, Wolfgang Poller, and Heinz-Peter Schultheiss
Circulation 2003;107:2793-2798; published online before print as doi:10.1161/01.CIR.0000072766.67150.51
[Abstract]
[Full text]
- Clinical Investigations and Reports
Interferon- Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction
- Uwe Kühl, Matthias Pauschinger, Peter Lothar Schwimmbeck, Bettina Seeberg, Conny Lober, Michel Noutsias, Wolfgang Poller, and Heinz-Peter Schultheiss
Circulation published May 27, 2003, doi:10.1161/01.CIR.0000072766.67150.51
[Abstract]
- Editorials
How Do ß-Blockers Improve Ventricular Function in Patients With Congestive Heart Failure?
- William H. Barry and E. Michael Gilbert
Circulation 2003;107:2395-2397, doi:10.1161/01.CIR.0000070984.65122.9C
[Full text]
- Brief Rapid Communications
Angiotensin II Type 2 Receptor Deficiency Exacerbates Heart Failure and Reduces Survival After Acute Myocardial Infarction in Mice
- Yuichiro Adachi, Yoshihiko Saito, Ichiro Kishimoto, Masaki Harada, Koichiro Kuwahara, Nobuki Takahashi, Rika Kawakami, Michio Nakanishi, Yasuaki Nakagawa, Keiji Tanimoto, Yoshitomo Saitoh, Shinji Yasuno, Satoru Usami, Masaru Iwai, Masatsugu Horiuchi, and Kazuwa Nakao
Circulation 2003;107:2406-2408; published online before print as doi:10.1161/01.CIR.0000072763.98069.B4
[Abstract]
[Full text]
- Cardiovascular Drugs
Eplerenone: Cardiovascular Protection
- Nancy J. Brown
Circulation 2003;107:2512-2518, doi:10.1161/01.CIR.0000071081.35693.9A
[Abstract]
[Full text]
- Articles
Angiotensin II Type 2 Receptor Deficiency Exacerbates Heart Failure and Reduces Survival After Acute Myocardial Infarction in Mice
- Yuichiro Adachi, Yoshihiko Saito, Ichiro Kishimoto, Masaki Harada, Koichiro Kuwahara, Nobuki Takahashi, Rika Kawakami, Michio Nakanishi, Yasuaki Nakagawa, Keiji Tanimoto, Yoshitomo Saitoh, Shinji Yasuno, Satoru Usami, Masaru Iwai, Masatsugu Horiuchi, and Kazuwa Nakao
Circulation published May 5, 2003, doi:10.1161/01.CIR.0000072763.98069.B4
[Abstract]
- Editorials
The Key to Unraveling the Mystery of Mortality in Heart Failure: An Integrated Approach
- Prakash C. Deedwania
Circulation 2003;107:1719-1721, doi:10.1161/01.CIR.0000014688.12415.C0
[Full text]
- Basic Science Reports
Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in Mice
- Tetsuo Shioi, Julie R. McMullen, Oleg Tarnavski, Kimber Converso, Megan C. Sherwood, Warren J. Manning, and Seigo Izumo
Circulation 2003;107:1664-1670; published online before print as doi:10.1161/01.CIR.0000057979.36322.88
[Abstract]
[Full text]
|
|
